Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Corvus Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted immuno-oncology and immune-mediated disease therapies. Its pipeline includes oral small molecules and monoclonal antibodies aimed at modulating immune cell signaling pathways, such as ITK inhibitors and adenosine receptor antagonists. The company targets cancers and inflammatory diseases, leveraging proprietary technology, strategic collaborations, and a focus on precision immune modulation to address large unmet medical needs.
This description was generated via AI from an annual report. Updated about 1 year ago.